Podcast

Trial Oversight Spotlight #4: Yvanne Enever

In this episode, Tom interviews Yvanne Enever, Founder and CEO of PHARMExcel. They delve into building quality partnerships between Sponsors and Service Providers, highlighting the valuable insights gained when things don't go as planned.

Key points:

  • Balancing needs of Academic vs Commercial Sponsors
  • Financial vs risk-based approaches in oversight
  • Preparing for GCP Revision 3 changes

Time stamps:

  • Yvanne Introduction -
  • Working with Diverse Sponsors -
  • Characteristics of Commercial Sponsors -
  • Insights on Academic Sponsors -
  • Case Study: Positive Sponsor Oversight -
  • Learning from Challenges -
  • A CRO Perspective on GCP R3 -
  • Essential Takeaways for Sponsor Oversight -

Guest Bio

Yvanne Enever

Yvanne Enever

Founder and CEO, PHARMExcel

Yvanne Enever, Founder and CEO of PHARMExcel, leads an ISO-accredited CRO for Phase I-IV clinical trials supporting UK academia, biopharma, and medical device organisations.

Previously, Yvanne led and spun out UCL's clinical trials unit and is widely recognised for her contributions, including co-authoring studies in The Lancet and being honoured as Businesswoman of the Year.

 

Host Bio

Tom Lazenby

Tom Lazenby

Founder & CEO

Tom is running the Trial Oversight Spotlight Interview Series where he meets with a variety of colleagues working in clinical research. They discuss a selection of the most important topics and decisions that are currently being navigated by all types of organisations delivering research.